Marisa Henriques Maria
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marisa Henriques Maria has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Berg
Department of Forensic Sciences, Division of Laboratory Medicine, Section of Drug Abuse Research, Oslo University Hospital, 0456 Oslo, Norway
5 shared publications - Nuno Rosa Neng
Laboratório de Ciências Forenses e Psicológicas Egas Moniz, Quinta da Granja, 2829-511 Caparica, Portugal
4 shared publications - Benedicte Jørgenrud
Section of Forensic Research, Department of Forensic Science, Oslo University Hospital
2 shared publications - Alexandre Quintas
Egas Moniz Center for Interdisciplinary Research (CiiEM), Egas Moniz School of Health & Science, 2829-511 Almada, Portugal
1 shared publication Galina Nilsson
Oslo Univ Hosp, Dept Forens Sci, Div Lab Med, Sect Forens Res, POB 4950, N-0424 Oslo, Norway
1 shared publication- Margarida Fonseca
Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal
1 shared publication
Latest Publications
- Open Access
Sorbent Strip Microextraction as a Practical Tool for Drug Screening: Application to Opioids and Local Anesthetics in Human Urine
The present contribution proposes a new design for adsorptive microextraction devices that promote a user-friendly and greener analytical approach. Novel Sorbent Strip Microextraction (SSμE) devices were made using a flexible adhesive film coated with convenient sorbents. Comparing the previous adsorptive microextraction devices, i.e., bar adsorptive microextraction and multi-sphere adsorptive microextraction, the main advantage of the sorbent strip device is its simple design and reduced device preparation time and waste. To demonstrate its applicability, three opioids (buprenorphine, tapentadol, and tramadol) and two local anesthetics (articaine and bupivacaine) were used as model compounds in urine matrices, followed by high-performance liquid chromatography with diode array detector (HPLC-DAD) analysis. Key parameters such as sorbent type, desorption conditions, and microextraction variables were systematically optimized by experimental designs. Under the final conditions, the method achieved recoveries ranging from 78% to 108%, trueness within ±7% and precision expressed by relative standard deviation below 13%. The technique demonstrated good linearity (r2 ≥ 0.9922) across dynamic ranges of 5–500 ng/mL for local anesthetics and 50–5000 ng/mL for opioids. The validated SSμE/HPLC-DAD methodology was successfully applied to real urine samples, confirming its high precision and accuracy. The proposed microextraction technique offers a practical, eco-friendly, and effective alternative for routine drug screening in complex biological matrices and presents significant advantages over traditional and other microextraction-based methods.
Open AccessSorbent Strip Microextraction as a Practical Tool for Drug Screening: Application to Opioids and Local Anesthetics in Human Urine
The present contribution proposes a new design for adsorptive microextraction devices that promote a user-friendly and greener analytical approach. Novel Sorbent Strip Microextraction (SSμE) devices were made using a flexible adhesive film coated with convenient sorbents. Comparing the previous adsorptive microextraction devices, i.e., bar adsorptive microextraction and multi-sphere adsorptive microextraction, the main advantage of the sorbent strip device is its simple design and reduced device preparation time and waste. To demonstrate its applicability, three opioids (buprenorphine, tapentadol, and tramadol) and two local anesthetics (articaine and bupivacaine) were used as model compounds in urine matrices, followed by high-performance liquid chromatography with diode array detector (HPLC-DAD) analysis. Key parameters such as sorbent type, desorption conditions, and microextraction variables were systematically optimized by experimental designs. Under the final conditions, the method achieved recoveries ranging from 78% to 108%, trueness within ±7% and precision expressed by relative standard deviation below 13%. The technique demonstrated good linearity (r2 ≥ 0.9922) across dynamic ranges of 5–500 ng/mL for local anesthetics and 50–5000 ng/mL for opioids. The validated SSμE/HPLC-DAD methodology was successfully applied to real urine samples, confirming its high precision and accuracy. The proposed microextraction technique offers a practical, eco-friendly, and effective alternative for routine drug screening in complex biological matrices and presents significant advantages over traditional and other microextraction-based methods.
- Open Access
- 10 January 2026
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 273, 117337
Simultaneous determination of three phosphatidylethanol homologues, 12 drugs and metabolites in whole blood by LC–MS/MS
- 10 January 2026
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 273, 117337
Open AccessSimultaneous determination of three phosphatidylethanol homologues, 12 drugs and metabolites in whole blood by LC–MS/MS
- Open Access
- 16 December 2025
- Published by MDPI AG in Separations
- Vol. 12 (12) , 341
Determination of Dextromethorphan and Dextrorphan in Urine Using Bar Adsorptive Microextraction Followed by Gas Chromatography–Mass Spectrometry Analysis
Over the past few years, the misuse of medications has progressively increased, posing a significant public health concern. This study proposed the development and validation of an alternative and greener analytical method for the determination of dextromethorphan (DXM) and its major metabolite, dextrorphan (DXO), in urine matrices using bar adsorptive microextraction (BAμE), followed by gas chromatography–mass spectrometry (GC-MS) analysis. Under optimized experimental conditions, average recoveries of 96.3% and 80.4% were achieved for DXM and DXO, respectively. The analytical limits obtained were 0.016 μg/mL for the limit of detection and 0.054 μg/mL for the limit of quantification. The working range was from 0.06 μg/mL to 2.0 μg/mL, with linearity for both compounds by determination coefficients (r2 > 0.99) and the goodness-of-fit and lack-of-fit tests. Intra-day precision and trueness yielded values below 8.77% and 16.28%, respectively, for both compounds. Inter-day precision and trueness values were below 7.67% and 9.73%, respectively. The application to 26 urine samples allowed the quantification of both compounds, with concentrations ranging from 0.06 to 3.21 μg/mL for DXM and 0.06 to 8.88 μg/mL for DXO. The method proved to be effective, selective, sensitive, simple, and cost-effective in the detection and quantification of DXM and DXO, reinforcing its applicability and feasibility in various laboratory contexts.
- 16 December 2025
- Published by MDPI AG in Separations
- Vol. 12 (12) , 341
Open AccessDetermination of Dextromethorphan and Dextrorphan in Urine Using Bar Adsorptive Microextraction Followed by Gas Chromatography–Mass Spectrometry Analysis
Over the past few years, the misuse of medications has progressively increased, posing a significant public health concern. This study proposed the development and validation of an alternative and greener analytical method for the determination of dextromethorphan (DXM) and its major metabolite, dextrorphan (DXO), in urine matrices using bar adsorptive microextraction (BAμE), followed by gas chromatography–mass spectrometry (GC-MS) analysis. Under optimized experimental conditions, average recoveries of 96.3% and 80.4% were achieved for DXM and DXO, respectively. The analytical limits obtained were 0.016 μg/mL for the limit of detection and 0.054 μg/mL for the limit of quantification. The working range was from 0.06 μg/mL to 2.0 μg/mL, with linearity for both compounds by determination coefficients (r2 > 0.99) and the goodness-of-fit and lack-of-fit tests. Intra-day precision and trueness yielded values below 8.77% and 16.28%, respectively, for both compounds. Inter-day precision and trueness values were below 7.67% and 9.73%, respectively. The application to 26 urine samples allowed the quantification of both compounds, with concentrations ranging from 0.06 to 3.21 μg/mL for DXM and 0.06 to 8.88 μg/mL for DXO. The method proved to be effective, selective, sensitive, simple, and cost-effective in the detection and quantification of DXM and DXO, reinforcing its applicability and feasibility in various laboratory contexts.
- Open Access
- 13 October 2023
- Published by Elsevier in Journal of Chromatography A
- Vol. 1711, 464451
An accurate and precise liquid chromatography–tandem mass spectrometry method for the determination of six phosphatidylethanol homologues in whole blood with phospholipid interferences minimized
- 13 October 2023
- Published by Elsevier in Journal of Chromatography A
- Vol. 1711, 464451
Open AccessAn accurate and precise liquid chromatography–tandem mass spectrometry method for the determination of six phosphatidylethanol homologues in whole blood with phospholipid interferences minimized
- Open Access
- 14 October 2022
- Published by Elsevier in Journal of Chromatography A
- Vol. 1684, 463566
Determination of eight phosphatidylethanol homologues in blood by reversed phase liquid chromatography–tandem mass spectrometry – How to avoid co-elution of phosphatidylethanols and unwanted phospholipids
- 14 October 2022
- Published by Elsevier in Journal of Chromatography A
- Vol. 1684, 463566
Open AccessDetermination of eight phosphatidylethanol homologues in blood by reversed phase liquid chromatography–tandem mass spectrometry – How to avoid co-elution of phosphatidylethanols and unwanted phospholipids